Sarisky
Daniel A. Sarisky, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20130159637 | SYSTEM AND METHOD FOR OPTIMALLY CREATING STORAGE OBJECTS IN A STORAGE SYSTEM - Systems and methods that enable the optimal creation of a storage object within a virtual storage system are disclosed. In accordance with embodiments, an optimal location with the storage system is determined in response to receiving an indication that a storage object is to be created within the storage system. The system and method prioritize physical storage resources in which to create the storage object, prioritize components to be provided access to the created storage object, and prioritize the interface between the physical storage resources and the accessing component. The storage object is optimally created within the storage system based on the priorities and based, at least in part, on other created storage objects. | 06-20-2013 |
Daniel Andrew Sarisky, Cary, NC US
Patent application number | Description | Published |
---|---|---|
20150052382 | FAILOVER METHODS AND SYSTEMS FOR A VIRTUAL MACHINE ENVIRONMENT - A storage provider executing a plurality of Web servers is provided for receiving a request from a management console managing a plurality of virtual machines. The management console uses a same address to send the request, regardless of which Web server is selected to process the request. The selected Web server re-sends the request to a second storage provider node instance, when a first storage provider node instance fails to process the request, where the first and the second storage provide node instances are executed by the storage provider as virtual machines for providing failover in processing requests. | 02-19-2015 |
20150052518 | METHOD AND SYSTEM FOR PRESENTING AND MANAGING STORAGE IN A VIRTUAL MACHINE ENVIRONMENT - Method and system for presenting storage in a virtual machine environment are provided. A storage volume is allocated to an existing profile, when the existing profile meets attributes for a requested storage and a new profile is generated when an existing profile does not meet the attributes and the storage volume is assigned to the new profile. | 02-19-2015 |
Robert Sarisky, Spring House, PA US
Patent application number | Description | Published |
---|---|---|
20110008352 | Toll-Like Receptor 3 Antagonists - Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed. | 01-13-2011 |
20120064095 | TOLL-LIKE RECEPTOR 3 ANTAGONISTS FOR THE TREATMENT OF METABOLIC AND CARDIOVASCULAR DISEASES - Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed. | 03-15-2012 |
20140255388 | TOLL LIKE RECEPTOR 3 ANTAGONISTS, METHODS AND USES - Toll Like Receptor 3 (TLR3) antagonists, polynucleotides encoding TLR3 antagonists or fragments, and methods of making and using the foregoing are disclosed. | 09-11-2014 |
Robert Sarisky, Yardley, PA US
Patent application number | Description | Published |
---|---|---|
20100166778 | Toll-Like Receptor 3 Antagonists - Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed. | 07-01-2010 |
Robert Sarisky, Lansdale, PA US
Patent application number | Description | Published |
---|---|---|
20130090457 | Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular Diseases - Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed. | 04-11-2013 |
20130244281 | Toll-Like Receptor 3 Antagonists - Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed. | 09-19-2013 |
20130280263 | Toll-Like Receptor 3 Antagonists - Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed. | 10-24-2013 |
20140017250 | Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular Diseases - Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed. | 01-16-2014 |
20140093508 | Toll-Like 3 Receptor Antagonists - Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed. | 04-03-2014 |
20140212426 | Toll-Like Receptor 3 Antagonists - Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed. | 07-31-2014 |
Robert T. Sarisky, Yardley, PA US
Patent application number | Description | Published |
---|---|---|
20090136512 | CXCL13 Antagonists and Their Use for the Treatment of Inflammatory Diseases - Methods of treating disorders related to CXCL13 activity utilize CXCL13 antagonists and, optionally, TNFα antagonists, such as antibodies, including specified portions or variants, polypeptides, polynucleotides, siRNA, shRNA, ribozymes, and DNAzymes. Disorders related to CXCL13 activity include inflammatory disorders, such as pulmonary disorders, for example, asthma, emphysema, and COPD, and systemic lupus erythematosus. | 05-28-2009 |
20100092462 | Methods for Suppressing Toll-Like Receptor Activity - Agents interfering with translocation of Toll-like receptor 3 (TLR3), methods of making and using the foregoing are disclosed. | 04-15-2010 |
Robert T. Sarisky, Radnor, PA US
Patent application number | Description | Published |
---|---|---|
20080299138 | Toll-Like Receptor 3 Modulators and Uses Thereof - Modulators of TLR3 activity and their use are disclosed. | 12-04-2008 |
Robert T. Sarisky, Lansdale, PA US
Patent application number | Description | Published |
---|---|---|
20120189643 | Toll Like Receptor 3 Antagonists, Methods and Uses - Toll Like Receptor 3 (TLR3) antagonists, polynucleotides encoding TLR3 antagonists or fragments thereof, and methods of making and using the foregoing are disclosed. | 07-26-2012 |